SEMICONDUCTOR ANALYTICS

Nanotechnology is helping those with lung disease breathe easier - create digital

 
 
Nanotechnology is helping those with lung disease breathe easiercreate digitalTiny biological messengers are being used by an Australian team that is devising new treatments for certain types of lung disease. The Lung Foundation ...
 
Related NewsFeeds

Asthma Therapeutics Market Latest Report with Forecast 2017 - 2025Honest VersionAsthma is a chronic disease of airways of the lungs and characterized by various symptoms such as bronchospasm, and pu

0 visits

$104.02 Million in Sales Expected for Accuray Incorporated (ARAY) This QuarterFairfield CurrentBrokerages expect Accuray Incorporated (NASDAQ:ARAY) to post sales of $104.02 million for the current f

0 visits

HIV infection linked to shorter survival in hepatocellular carcinomaHealioHIV seropositivity appeared associated with shorter OS among patients with hepatocellular carcinoma despite sufficient antir

0 visits

Investor Outlook: Cannabis Science Inc (CBIS) "Buy" Rating Kept by Analysts at Beacon Today | Thorold NewsThorold NewsInvestors sentiment is 0 in 2018 Q3. Its the same as in 2018Q2. It is without ch

0 visits

School run banned to save pupils from breathing toxic airExpressA BAN on the school run for children across the UK is being piloted in a drastic attempt to cut toxic levels of air pollution. Thousan

0 visits

Pulmonary Function Testing Systems 2019 Global Market Outlook,Research,Trends and Forecast to 2023 - Press ReleaseDigital Journal"Pulmonary Function Testing Systems Market"WiseGuyReports.Com Publish

0 visits

New research prize for best doctoral thesis on cancerEurekAlertThis year, the Swedish medical university Karolinska Institutet for the first time awards a research prize in memory of Professor Dan G

0 visits

Tivozanib shows PFS benefit over sorafenib for advanced kidney cancerHealioSAN FRANCISCO - Tivozanib induced higher 2-year PFS and objective response rates than sorafenib among patients with refract

0 visits

Study Reveals Immunotherapy Likely To Offer Better Kidney Cancer TreatmentIndustry News CenterThere seems to be a paradigm shift and evolvement in the typical way doctors approach the treatment of k

0 visits

All Points North #41: Platforms, promises and platitudes - Blue ReformYLE NewsThe new party of high-profile ex-Finns Party MPs and ministers has performed poorly in public polls, casting doubt on th

0 visits

IL-5-Inhibiting Agents Mepolizumab, Benralizumab, and ReslizumabAJMC.com Managed Markets NetworkExperts review the IL-5-inhibiting agents mepolizumab, benralizumab, and reslizumab.

0 visits

Telehealth Program to Drive Patient Care Access in AppalachiaPatientEngagementHIT.comA new grant from the National Science Foundation will create a telehealth program with UVA Health System, driving

0 visits

Eczema Causes and TreatmentsBrit + CoDry, flaky skin is a common side effect of cold weather; but while we often refer to any form as "eczema,? those who actually have this condition will tell you i

28 visits

Breast Cancer Drugs Market | Size | Share | Industry Analysis 2019-2025 | PBIGPopenPRA research and development in Breast cancer treatment market. Breast cancer is a disease where uncontrolled growt

0 visits

Clovis Oncology to Present at the 8th Annual SVB Leerink Healthcare ConferenceClearfield ProgressBOULDER, Colo.--(BUSINESS WIRE)--Feb 22, 2019--Clovis Oncology, Inc. (Nasdaq: CLVS) today announced t

0 visits

Insmed Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Business UpdatePRNewswireBRIDGEWATER, N.J., Feb. 22, 2019 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a global

0 visits

Apollo Medical (AMEH) vs. CleanTech Innovations (SIXD) Head to Head ReviewFairfield CurrentApollo Medical (NASDAQ:AMEH) and CleanTech Innovations (OTCMKTS:SIXD) are both small-cap medical companies,

0 visits

Oncology Drugs Market Analysis (2019- 2025)| Roche, HENGRUI, AstraZeneca, QILU, SanofiHonest VersionLos Angeles, United State, Feb 22, 2019- The report presents key information and data related to t

0 visits

Sensus Healthcare Inc Expected to Post Q4 2019 Earnings of $0.05 Per Share (SRTS)PressOracleSensus Healthcare Inc (NASDAQ:SRTS) - Analysts at B. Riley reduced their Q4 2019 EPS estimates for Sensus

0 visits

Plasmonics technologies take on global challengesphysicsworld.comIn 1861 James Clerk Maxwell rewrote our understanding of light when he began publishing a description of it in terms of electric and

0 visits